tiprankstipranks
Compass Therapeutics (CMPX)
NASDAQ:CMPX
US Market

Compass Therapeutics (CMPX) Financial Statements

196 Followers

Compass Therapeutics Financial Overview

Compass Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.351; its P/E ratio is -2.33; Compass Therapeutics is scheduled to report earnings on July 31, 2024, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -15.39M$ -9.96M$ -11.28M$ -9.74M$ -12.89M
EBITDA$ -14.93M-$ -11.84M$ -9.85M$ -13.01M
Net Income Common Stockholders$ -13.41M$ -9.96M$ -11.28M$ 11.59M$ -11.59M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 152.46M$ 163.70M$ 168.75M$ 175.17M$ 186.61M
Total Assets$ 156.88M$ 170.04M$ 179.18M$ 186.60M$ 199.65M
Total Debt$ 1.73M$ 2.04M$ 2.34M$ 2.64M$ 2.94M
Net Debt$ -150.73M$ -161.66M$ -166.41M$ -172.53M$ -183.67M
Total Liabilities$ 8.34M$ 9.99M$ 10.89M$ 12.71M$ 18.01M
Stockholders Equity$ 148.54M$ 160.04M$ 168.29M$ 175.26M$ 181.64M
Cash Flow-
Free Cash Flow$ -12.36M-$ -10.12M$ -12.23M$ -10.70M
Operating Cash Flow$ -12.35M$ -5.92M$ -10.11M$ -12.23M$ -10.64M
Investing Cash Flow$ 6.31M$ 17.05M$ -667.00K$ 4.27M$ -46.65M
Financing Cash Flow$ -158.00K$ 21.00K$ 3.03M$ 41.00K$ 75.75M
Currency in USD

Compass Therapeutics Earnings and Revenue History

Compass Therapeutics Debt to Assets

Compass Therapeutics Cash Flow

Compass Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis